Trial intelligence / Profile preview

Etanercept in Adult Patients with Active, Severe and Advanced Axial Ankylosing Spondylitis

2006-002748-27Phase 4Completed

Sponsor
Wyeth
Start
Nov 2006
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in ankylosing spondylitis (AS) comparing Etanercept arm with Placebo arm (2 arms). Primary endpoint: BASDAI 50 response at week 12. Started Nov 2006; status: completed.

02

Drugs

etanercept
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on 2006-002748-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002748-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call